Company Overview - Oric Pharmaceuticals, Inc. (ORIC) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance expectations [4] Performance Metrics - Over the past week, ORIC shares have increased by 14.08%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 5.43% [6] - In a longer time frame, ORIC's monthly price change is 104.01%, significantly higher than the industry's 7.54% [6] - Over the last quarter, ORIC shares have risen by 28.76%, and over the past year, they are up 25.91%, while the S&P 500 has only moved 8.33% and 12.92%, respectively [7] Trading Volume - ORIC's average 20-day trading volume is 1,988,020 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, 5 earnings estimates for ORIC have been revised upwards, while only 1 has been revised downwards, leading to an increase in the consensus estimate from -$2.06 to -$1.75 [10] - For the next fiscal year, 3 estimates have moved upwards, with 1 downward revision during the same period [10] Conclusion - Given the strong performance metrics and positive earnings outlook, ORIC is positioned as a promising investment opportunity with a Momentum Score of A [12]

Company Overview - Sagimet Biosciences Inc. (SGMT) currently holds a Momentum Style Score of B, indicating a favorable momentum outlook [3] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [4] Price Performance - SGMT shares have increased by 56.62% over the past week, significantly outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 5.43% during the same period [6] - Over the past month, SGMT's price change is 86.79%, compared to the industry's 8.65% [6] - In the last three months, SGMT shares have risen by 54.29%, and they are up 19.76% over the past year, while the S&P 500 has only moved 7.87% and 14.01%, respectively [7] Trading Volume - SGMT's average 20-day trading volume is 1,939,129 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, four earnings estimates for SGMT have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from -$3.68 to -$2.49 [10] - For the next fiscal year, three estimates have moved upwards, with one downward revision noted [10] Conclusion - Considering the positive momentum indicators and earnings outlook, SGMT is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1][2]. Company Overview: Grifols (GRFS) - Grifols currently holds a Momentum Style Score of A, indicating strong momentum potential [3]. - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4]. Performance Metrics - Over the past week, Grifols shares increased by 2.47%, while the Zacks Medical - Drugs industry remained flat [6]. - In a longer timeframe, Grifols' shares have risen by 15.44% over the past month, significantly outperforming the industry's 3.53% [6]. - For the past quarter, Grifols shares increased by 8.89%, and over the last year, they gained 15.12%, compared to the S&P 500's 3.59% and 14.21% respectively [7]. Trading Volume - Grifols has an average 20-day trading volume of 819,084 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the last two months, one earnings estimate for Grifols has increased, while none have decreased, raising the consensus estimate from $0.96 to $0.99 [10]. - For the next fiscal year, one estimate has also moved upwards with no downward revisions [10]. Conclusion - Given the strong performance metrics and positive earnings outlook, Grifols is recommended as a solid momentum pick for investors [11][12].

Company Overview - Delcath Systems, Inc. (DCTH) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance [4] Performance Metrics - DCTH shares have increased by 0.62% over the past week, outperforming the Zacks Medical - Instruments industry, which rose by 0.37% [6] - Over the past month, DCTH's price change is 37.2%, significantly higher than the industry's 1.13% [6] - In the last quarter, DCTH shares have risen by 36.27%, and over the past year, they have gained 149.3%, while the S&P 500 has only moved 2.37% and 14.4%, respectively [7] Trading Volume - The average 20-day trading volume for DCTH is 588,239 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for DCTH has increased, while none have decreased, raising the consensus estimate from $0.28 to $0.29 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the strong performance metrics and positive earnings outlook, DCTH is positioned as a promising momentum pick for investors [12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Catalyst Pharmaceutical (CPRX) - Catalyst Pharmaceutical currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Price Performance - CPRX shares have increased by 1.92% over the past week, while the Zacks Medical - Drugs industry remained flat [5] - Over the past month, CPRX's price change is 8.02%, outperforming the industry's 3.76% [5] - In the last quarter, shares of CPRX have risen by 18.84%, and over the past year, they have gained 55.3%, compared to the S&P 500's increases of 2.37% and 14.4%, respectively [6] Trading Volume - The average 20-day trading volume for CPRX is 1,094,588 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, four earnings estimates for CPRX have been revised upwards, while none have been revised downwards, leading to an increase in the consensus estimate from $2.15 to $2.25 [9] - For the next fiscal year, three estimates have moved up, while one has been revised down [9] Conclusion - Considering the strong momentum indicators and positive earnings outlook, CPRX is identified as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]

Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] - The Zacks Momentum Style Score helps investors identify stocks with strong momentum, addressing the challenges of defining momentum [2] Company Overview: Groupon (GRPN) - Groupon currently holds a Momentum Style Score of B, indicating potential for solid momentum [3] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Performance Metrics - Over the past week, GRPN shares increased by 2.88%, while the Zacks Internet - Commerce industry remained flat [6] - In the last month, GRPN's price change was 63.47%, significantly outperforming the industry's 3.89% [6] - Over the past quarter, GRPN shares surged by 176.38%, and gained 84.02% over the last year, compared to the S&P 500's -0.52% and 14.2% respectively [7] Trading Volume - GRPN's average 20-day trading volume is 1,764,950 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - Recent earnings estimate revisions for GRPN have been positive, with three estimates moving higher and none lower, raising the consensus estimate from -$0.14 to $0.20 over the past 60 days [10] - For the next fiscal year, two estimates have increased with no downward revisions, indicating a favorable earnings outlook [10] Conclusion - Considering the positive momentum indicators and earnings outlook, GRPN is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [12]

Company Overview - Carvana (CVNA) currently holds a Momentum Style Score of B, indicating potential for strong performance based on recent trends [3] - The company has a Zacks Rank of 1 (Strong Buy), suggesting it is expected to outperform the market [4] Price Performance - Over the past week, Carvana's shares increased by 1.41%, while the Zacks Internet - Commerce industry remained flat [6] - In the last month, Carvana's stock price rose by 26.91%, significantly outperforming the industry's 7.67% [6] - Over the past quarter, shares of Carvana have surged by 71.07%, and over the last year, they have increased by 212.19% [7] - In contrast, the S&P 500 has shown a movement of -0.42% over the last quarter and 13.57% over the last year [7] Trading Volume - Carvana's average 20-day trading volume is 4,037,623 shares, which is a useful indicator of market interest and momentum [8] Earnings Outlook - In the past two months, four earnings estimates for Carvana have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $3.52 to $4.64 [10] - For the next fiscal year, six estimates have moved higher, with no downward revisions during the same period [10] Conclusion - Considering the positive price trends, strong earnings outlook, and favorable trading volume, Carvana is positioned as a strong momentum pick with a Momentum Score of B and a Zacks Rank of 1 (Strong Buy) [12]

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for profitable short-term investing, highlighting the use of a specific screening strategy to identify stocks with strong fundamentals and positive price momentum [1][2]. Group 1: Stock Screening Strategy - The "Recent Price Strength" screen is designed to identify stocks with sufficient fundamental strength to maintain their recent uptrend, focusing on those trading in the upper portion of their 52-week high-low range, indicating bullishness [3]. - Mirion Technologies, Inc. (MIR) is identified as a suitable candidate that has shown a solid price increase of 29% over the past 12 weeks, reflecting investor confidence in its potential upside [4]. - The stock has also experienced a price increase of 23.6% over the past four weeks, confirming that the upward trend is still intact [5]. Group 2: Fundamental Strength Indicators - MIR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [6]. - The Zacks Rank system has a strong track record, with Zacks Rank 1 stocks averaging an annual return of +25% since 1988, indicating the effectiveness of this ranking system [7]. - The Average Broker Recommendation for MIR is 1 (Strong Buy), suggesting high optimism from the brokerage community regarding the stock's near-term performance [7]. Group 3: Investment Opportunities - In addition to MIR, there are several other stocks that meet the criteria of the "Recent Price Strength" screen, providing additional investment opportunities for trend-focused investors [8]. - The article suggests that investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [8].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Company Overview: CarGurus (CARG) - CarGurus currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting a favorable outlook compared to the market [3] Performance Metrics - Over the past week, CarGurus shares increased by 4.44%, while the Zacks Automotive - Replacement Parts industry rose by 5.16% [5] - In a longer timeframe, CarGurus shares have appreciated by 1.12% over the past quarter and 33.05% over the last year, outperforming the S&P 500, which saw declines of -2.56% and gains of 11.12% respectively [6] Trading Volume - The average 20-day trading volume for CarGurus is 1,038,208 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, five earnings estimates for CarGurus have been revised upwards, increasing the consensus estimate from $1.85 to $2.15 [9] - For the next fiscal year, five estimates have also moved higher, with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, CarGurus is positioned as a 1 (Strong Buy) stock with a Momentum Score of A, making it a compelling investment option [11]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Investors following momentum investing avoid cheap stocks and instead focus on fast-moving stocks [1] - Identifying the right entry point for trending stocks can be challenging, as they may lose momentum if future growth does not justify their high valuations [1] Group 2: Bargain Stocks with Momentum - Investing in bargain stocks that have recently shown price momentum may be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Mogo Inc (MOGO) Analysis - Mogo Inc (MOGO) has seen a price increase of 51.2% over the past four weeks, indicating growing investor interest [3] - The stock gained 25% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - MOGO has a high beta of 3.47, suggesting it moves 247% higher than the market in either direction [4] Group 4: Valuation and Earnings Estimates - MOGO has a Momentum Score of B, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investors [6] - MOGO is trading at a Price-to-Sales ratio of 0.63, meaning investors pay 63 cents for each dollar of sales, indicating a reasonable valuation [6] Group 5: Additional Investment Opportunities - Besides MOGO, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen [7] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles [8]